Serotonin–norepinephrine releasing agent
A serotonin–norepinephrine releasing agent (SNRA) is a type of drug which induces the release of serotonin and norepinephrine (and epinephrine) in the body and/or brain.
Only a few SNRAs are known, examples of which include norfenfluramine, (R)-MDMA, MBDB, and MDAI. Fenfluramine/phentermine (Fen-Phen), a combination formulation of fenfluramine, a serotonin releasing agent, and phentermine, a norepinephrine releasing agent, is a functional SNRA that was formerly used as an appetite suppressant for the treatment of obesity.
A closely related type of drug is a serotonin–norepinephrine reuptake inhibitor (SNRI).
See also
[edit]- Monoamine releasing agent
- Serotonin releasing agent
- Norepinephrine releasing agent
- Serotonin–dopamine releasing agent
- Serotonin–norepinephrine–dopamine releasing agent
References
[edit]
 | This pharmacology-related article is a stub. You can help Wikipedia by expanding it. |